Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with β-thalassemia major

Objective: The main objectives of this study were to investigate the prevalence of hepatitis C virus (HCV) among patients with β-thalassemia major and to determine the most prevalent genotype for this virus.Materials and Methods: One hundred twenty-two β-thalassemia major patients who were previousl...

Full description

Bibliographic Details
Main Authors: Suleimman Ahmad Al-Sweedan, Said Jaradat, Khitam Amer, Wail Hayajneh, Hazem Haddad
Format: Article
Language:English
Published: Galenos Publishing House 2011-03-01
Series:Turkish Journal of Hematology
Subjects:
Online Access:http://www.journalagent.com/z4/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-65872
_version_ 1797704825598640128
author Suleimman Ahmad Al-Sweedan
Said Jaradat
Khitam Amer
Wail Hayajneh
Hazem Haddad
author_facet Suleimman Ahmad Al-Sweedan
Said Jaradat
Khitam Amer
Wail Hayajneh
Hazem Haddad
author_sort Suleimman Ahmad Al-Sweedan
collection DOAJ
description Objective: The main objectives of this study were to investigate the prevalence of hepatitis C virus (HCV) among patients with β-thalassemia major and to determine the most prevalent genotype for this virus.Materials and Methods: One hundred twenty-two β-thalassemia major patients who were previously diagnosed at the molecular level were included. All plasma samples were tested for the presence of antibodies by ELISA. Real-time polymerase chain reaction (PCR) was used in the quantitation the HCV RNA viral loads, and consequently, patients with high virus titer were genotyped by the linear array.Results: Forty of the patients were anti-HCV positive. The prevalence of anti-HCV was significantly higher in patients who received blood transfusion before 1993 (83.7%) than in those who received it after 1993 (16.3%) (p=0.000). β-thalassemia major patients with HCV infection had significantly higher rates of elevated aspartate aminotransferase (54.4% vs 40.5%, p=0.045) and alanine aminotransferase (72.47% vs 37.47%, p=0.00) and of splenectomy (54.8% vs 45.2%, p=0.004) than β-thalassemia major patients without HCV.Conclusion: HCV genotype 4 is the commonest genotype in multi-transfused patients with β-thalassemia major in Jordan.
first_indexed 2024-03-12T05:27:08Z
format Article
id doaj.art-dcdf370237724883bf4f4dba251dca32
institution Directory Open Access Journal
issn 1300-7777
1308-5263
language English
last_indexed 2024-03-12T05:27:08Z
publishDate 2011-03-01
publisher Galenos Publishing House
record_format Article
series Turkish Journal of Hematology
spelling doaj.art-dcdf370237724883bf4f4dba251dca322023-09-03T07:22:06ZengGalenos Publishing HouseTurkish Journal of Hematology1300-77771308-52632011-03-0128014751Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with β-thalassemia majorSuleimman Ahmad Al-SweedanSaid JaradatKhitam AmerWail HayajnehHazem HaddadObjective: The main objectives of this study were to investigate the prevalence of hepatitis C virus (HCV) among patients with β-thalassemia major and to determine the most prevalent genotype for this virus.Materials and Methods: One hundred twenty-two β-thalassemia major patients who were previously diagnosed at the molecular level were included. All plasma samples were tested for the presence of antibodies by ELISA. Real-time polymerase chain reaction (PCR) was used in the quantitation the HCV RNA viral loads, and consequently, patients with high virus titer were genotyped by the linear array.Results: Forty of the patients were anti-HCV positive. The prevalence of anti-HCV was significantly higher in patients who received blood transfusion before 1993 (83.7%) than in those who received it after 1993 (16.3%) (p=0.000). β-thalassemia major patients with HCV infection had significantly higher rates of elevated aspartate aminotransferase (54.4% vs 40.5%, p=0.045) and alanine aminotransferase (72.47% vs 37.47%, p=0.00) and of splenectomy (54.8% vs 45.2%, p=0.004) than β-thalassemia major patients without HCV.Conclusion: HCV genotype 4 is the commonest genotype in multi-transfused patients with β-thalassemia major in Jordan.http://www.journalagent.com/z4/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-65872Virologytransfusionthalassemia
spellingShingle Suleimman Ahmad Al-Sweedan
Said Jaradat
Khitam Amer
Wail Hayajneh
Hazem Haddad
Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with β-thalassemia major
Turkish Journal of Hematology
Virology
transfusion
thalassemia
title Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with β-thalassemia major
title_full Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with β-thalassemia major
title_fullStr Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with β-thalassemia major
title_full_unstemmed Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with β-thalassemia major
title_short Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with β-thalassemia major
title_sort seroprevalence and genotyping of hepatitis c virus in multiple transfused jordanian patients with β thalassemia major
topic Virology
transfusion
thalassemia
url http://www.journalagent.com/z4/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-65872
work_keys_str_mv AT suleimmanahmadalsweedan seroprevalenceandgenotypingofhepatitiscvirusinmultipletransfusedjordanianpatientswithbthalassemiamajor
AT saidjaradat seroprevalenceandgenotypingofhepatitiscvirusinmultipletransfusedjordanianpatientswithbthalassemiamajor
AT khitamamer seroprevalenceandgenotypingofhepatitiscvirusinmultipletransfusedjordanianpatientswithbthalassemiamajor
AT wailhayajneh seroprevalenceandgenotypingofhepatitiscvirusinmultipletransfusedjordanianpatientswithbthalassemiamajor
AT hazemhaddad seroprevalenceandgenotypingofhepatitiscvirusinmultipletransfusedjordanianpatientswithbthalassemiamajor